These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25510328)

  • 1. Smear plus Detect-TB for a sensitive diagnosis of pulmonary tuberculosis: a cost-effectiveness analysis in an incarcerated population.
    Schmid KB; Scherer L; Barcellos RB; Kuhleis D; Prestes IV; Steffen RE; Dalla Costa ER; Rossetti ML
    BMC Infect Dis; 2014 Dec; 14():678. PubMed ID: 25510328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of PCR for the rapid diagnosis of pulmonary tuberculosis.
    Scherer LC; Sperhacke RD; Ruffino-Netto A; Rossetti ML; Vater C; Klatser P; Kritski AL
    BMC Infect Dis; 2009 Dec; 9():216. PubMed ID: 20043842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is introducing rapid culture into the diagnostic algorithm of smear-negative tuberculosis cost-effective?
    Yakhelef N; Audibert M; Varaine F; Chakaya J; Sitienei J; Huerga H; Bonnet M
    Int J Tuberc Lung Dis; 2014 May; 18(5):541-6. PubMed ID: 24903790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of routine diagnostic evaluation of pulmonary tuberculosis in a primary care unit in Brazil.
    Guerra RL; Dorman SE; Luiz RR; Conde MB
    Int J Tuberc Lung Dis; 2013 Oct; 17(10):1336-40. PubMed ID: 24025387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of the Xpert® MTB/RIF assay for tuberculosis diagnosis in Brazil.
    Pinto M; Steffen RE; Cobelens F; van den Hof S; Entringer A; Trajman A
    Int J Tuberc Lung Dis; 2016 May; 20(5):611-8. PubMed ID: 27084814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of the use of PCR assay in diagnosing pulmonary TB in a low-incidence area.
    Rajalahti I; Ruokonen EL; Kotomäki T; Sintonen H; Nieminen MM
    Eur Respir J; 2004 Mar; 23(3):446-51. PubMed ID: 15065837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of the Xpert MTB/RIF assay for rapid diagnosis of suspected tuberculosis in an intermediate burden area.
    You JH; Lui G; Kam KM; Lee NL
    J Infect; 2015 Apr; 70(4):409-14. PubMed ID: 25573001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriologically-confirmed pulmonary tuberculosis in an Ethiopian prison: Prevalence from screening of entrant and resident prisoners.
    Tsegaye Sahle E; Blumenthal J; Jain S; Sun S; Young J; Manyazewal T; Woldeamanuel H; Teferra L; Feleke B; Vandenberg O; Rey Z; Briggs-Hagen M; Haubrich R; Amogne W; McCutchan JA
    PLoS One; 2019; 14(12):e0226160. PubMed ID: 31830092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role and performance of chest X-ray for the diagnosis of tuberculosis: a cost-effectiveness analysis in Nairobi, Kenya.
    van Cleeff MR; Kivihya-Ndugga LE; Meme H; Odhiambo JA; Klatser PR
    BMC Infect Dis; 2005 Dec; 5():111. PubMed ID: 16343340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical diagnostic performance of the simultaneous amplification and testing methods for detection of the Mycobacterium tuberculosis complex for smear-negative or sputum-scarce pulmonary tuberculosis in China.
    Fan L; Zhang Q; Cheng L; Liu Z; Ji X; Cui Z; Ju J; Xiao H
    Chin Med J (Engl); 2014; 127(10):1863-7. PubMed ID: 24824246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening pulmonary tuberculosis suspects in Malawi: testing different strategies.
    Harries AD; Kamenya A; Subramanyam VR; Maher D; Squire SB; Wirima JJ; Nyangulu DS; Nunn P
    Trans R Soc Trop Med Hyg; 1997; 91(4):416-9. PubMed ID: 9373637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs and cost-effectiveness of Gene Xpert compared to smear microscopy for the diagnosis of pulmonary tuberculosis using real-world data from Arsi zone, Ethiopia.
    Kaso AW; Hailu A
    PLoS One; 2021; 16(10):e0259056. PubMed ID: 34695153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleach treatment of sputum samples aids pulmonary tuberculosis screening among HIV-infected patients in Laos.
    Thammavong C; Paboriboune P; Bouchard B; Harimanana A; Babin FX; Phimmasone P; Berland JL; Buisson Y
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1353-8. PubMed ID: 22283894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis.
    Dowdy DW; Steingart KR; Pai M
    PLoS Med; 2011 Aug; 8(8):e1001074. PubMed ID: 21857810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis.
    Dowdy DW; O'Brien MA; Bishai D
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1021-9. PubMed ID: 18713499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of a molecular assay to detect Mycobacterium tuberculosis complex DNA in clinical specimens: multicenter study in Brazil.
    Verza M; Schmid KB; Barcellos RB; Linck N; Bello GL; Scapin D; Sperhacke RD; Silva MS; Wollheim C; Rivero MG; Kritski AL; Rezende L; Oliveira MM; Costa ER; Rossetti ML
    Mem Inst Oswaldo Cruz; 2017 Feb; 112(2):94-99. PubMed ID: 28177043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of the enhanced Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for rapid diagnosis of tuberculosis in prison inmates.
    Bergmann JS; Yuoh G; Fish G; Woods GL
    J Clin Microbiol; 1999 May; 37(5):1419-25. PubMed ID: 10203498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive comparison of Ziehl-Neelsen and fluorescence microscopy for the diagnosis of tuberculosis in a resource-poor urban setting.
    Kivihya-Ndugga LE; van Cleeff MR; Githui WA; Nganga LW; Kibuga DK; Odhiambo JA; Klatser PR
    Int J Tuberc Lung Dis; 2003 Dec; 7(12):1163-71. PubMed ID: 14677891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.
    Walusimbi S; Kwesiga B; Rodrigues R; Haile M; de Costa A; Bogg L; Katamba A
    BMC Health Serv Res; 2016 Oct; 16(1):563. PubMed ID: 27724908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
    Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
    BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.